The healthfulness care sector includes companies that produce medical goods, such as drugs and medical devices, and throngs that provide medical services, such as health insurance or hospital administration. Here are the 10 biggest condition care companies based on 12-month trailing (TTM) revenue as of March 24, 2020. This list is limited to companies which are publicly traded in the U.S. or Canada, either straight or through ADRs.
The parent company of a leading drugstore chain, CVS Health Corp. also is among the biggest pharmaceutics benefit management (PBM) companies. Additionally, through its 2018 acquisition of Aetna, CVS has become a major player in health protection.
- Revenue (TTM): $240.3 billion
- Net Income (TTM): $13.8 billion
- Market Cap: $184.8 billion
- 1-Year Trailing Total Amends: -19.8%
- P/E Ratio (TTM): 13.6
UnitedHealth Group is a health insurance company that also provides data analytics and consulting marines to health care providers, as well as pharmacy care services. Its principal divisions include UnitedHealthcare, OptumHealth, OptumInsight, and OptumRx.
- Receipts (TTM): $224.9 billion
- Net Income (TTM): -$917.0 million
- Market Cap: $18.7 billion
- 1-Year Trailing Total Return: -1.2%
- P/E Proportion (TTM): N/A
McKesson Corp. is a distributor of pharmaceuticals and other medical products in the U.S., Canada, and Europe. Bansi Nagji, executive evil president and chief strategy and business development officer, is stepping down from this role effective Step 31, 2020. He will remain with the company in an advisory role to smooth the transition. McKesson expects to name a successor within the next few months.
- Returns (TTM): $182.1 billion
- Net Income (TTM): $649.4 million
- Market Cap: $15.2 billion
- 1-Year Trailing Total Return: -4.4%
- P/E Proportion (TTM): 23.9
AmerisourceBergen Corp. is a distributor of medications and medical supplies. The company is in the process of exiting its PharMEDium compounding business as the sequel of “ongoing operational, regulatory, and commercial challenges.”
- Revenue (TTM): $153.7 billion
- Net Income (TTM): $5.1 billion
- Market Cap: $48.4 billion
- 1-Year Stalk Total Return: -21.7%
- P/E Ratio (TTM): 9.7
Cigna Corp. offers medical, life, and accident insurance products, as well as controlled care services.
- Revenue (TTM): $149.7 billion
- Net Income (TTM): -$4.2 billion
- Market Cap: $12.0 billion
- 1-Year Drag Total Return: -12.3%
- P/E Ratio (TTM): N/A
Cardinal Health is a manufacturer of medical, surgical, and laboratory products, as well as a distributor of knock outs and health care supplies. Effective May 12, 2020, Jason Hollar will assume the CFO post at Cardinal Health. He was sundry recently the
- Revenue (TTM): $137.4 billion
- Net Income (TTM): $3.7 billion
- Market Cap: $38.6 billion
- 1-Year Trailing Come to Return: -27.8%
- P/E Ratio (TTM): 10.7
Walgreens Boots Alliance operates drug stores in the U.S. under the Walgreens and Duane Reade favours, as well as Boots drug stores in the U.K. and various other countries. In the U.S. during recent years, Walgreens has acquired a chunky number of store locations from competitor Rite Aid Corp. (
- Revenue (TTM): $104.2 billion
- Net Income (TTM): $4.8 billion
- Peddle Cap: $44.1 billion
- 1-Year Trailing Total Return: -41.4%
- P/E Ratio (TTM): 9.5
Anthem is a health insurance company that come forwards individual, employer-sponsored, Medicare, and Medicaid plans. In 2020, Anthem completed the acquisition of Beacon Health Options, “the largest independently embraced behavioral health organization in the country serving more than 36 million people across all 50 delineates.”
- Revenue (TTM): $82.1 billion
- Net Income (TTM): $15.1 billion
- Market Cap: $293.0 billion
- 1-Year Trailing Total Repayment: -16.6%
- P/E Ratio (TTM): 19.7
Johnson & Johnson manufactures prescription pharmaceuticals, over-the-counter health care products, and medical devices. BAND-AID maker adhesive bandages are among its best-known consumer products. While noting that they are working with multiple schemes to develop “fast-track solutions” for the COVID-19 coronavirus, Johnson & Johnson warns investors to discount “anecdotal, unsubstantiated turn ups” that HIV treatment darunavir (DRV) may be effective against COVID-19. The company is screening various antiviral compounds, containing darunavir, as possible COVID-19 treatments, but it is too early to tell which, if any, may prove to be effective.
- Revenue (TTM): $74.6 billion
- Net Takings (TTM): $1.3 billion
- Market Cap: $26.7 billion
- 1-Year Trailing Total Return: -20.3%
- P/E Ratio (TTM): 14.5
Centene Corp. is a preside overed health care company, focusing on administering government-sponsored programs. In January 2020, Centene acquired WellCare Vigour Plans Inc., thereby increasing its market share in Medicaid, Medicare Advantage, and Medicare Prescription Drug Plans.